ReproCELL Incorporated
TSE:4978.T
107 (JPY) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,426.817 | 2,953.271 | 2,234.568 | 1,286.283 | 1,199.908 | 1,088.527 | 926.255 | 1,257.812 | 1,066.373 | 567.001 | 460.95 | 420.077 | 316.524 |
| Cost of Revenue
| 1,322.095 | 1,812.024 | 1,431.129 | 803.582 | 725.2 | 592.074 | 545.05 | 681.739 | 533.432 | 290.948 | 204.846 | 196.309 | 156.667 |
| Gross Profit
| 1,104.722 | 1,141.247 | 803.439 | 482.701 | 474.708 | 496.453 | 381.205 | 576.073 | 532.941 | 276.053 | 256.104 | 223.768 | 159.857 |
| Gross Profit Ratio
| 0.455 | 0.386 | 0.36 | 0.375 | 0.396 | 0.456 | 0.412 | 0.458 | 0.5 | 0.487 | 0.556 | 0.533 | 0.505 |
| Reseach & Development Expenses
| 384.953 | 501.508 | 535.287 | 662.029 | 454.756 | 273.219 | 191.634 | 276.449 | 289.344 | 280.161 | 120.075 | 115.319 | 118.127 |
| General & Administrative Expenses
| 1,145.312 | 995.963 | 915.277 | 868.718 | 928.888 | 1,004.352 | 1,215.352 | 1,243.926 | 1,268.024 | 736.545 | 229.307 | 153.588 | 138.979 |
| Selling & Marketing Expenses
| -16.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,129.062 | 995.963 | 915.277 | 868.718 | 928.888 | 1,004.352 | 1,215.352 | 1,243.926 | 1,268.024 | 736.545 | 229.307 | 153.588 | 138.979 |
| Other Expenses
| 314.195 | 130.495 | 173.498 | 221.023 | 66.998 | 49.25 | 77.989 | 74.035 | 67.242 | 125.904 | -4.178 | 52.468 | 76.29 |
| Operating Expenses
| 1,514.015 | 1,497.471 | 1,450.564 | 1,530.747 | 1,383.644 | 1,277.571 | 1,406.986 | 1,520.375 | 1,557.368 | 1,016.706 | 349.382 | 268.907 | 257.106 |
| Operating Income
| -409.293 | -356.224 | -647.127 | -1,048.046 | -908.936 | -781.118 | -1,025.782 | -944.304 | -1,024.428 | -740.654 | -93.279 | -45.14 | -97.25 |
| Operating Income Ratio
| -0.169 | -0.121 | -0.29 | -0.815 | -0.758 | -0.718 | -1.107 | -0.751 | -0.961 | -1.306 | -0.202 | -0.107 | -0.307 |
| Total Other Income Expenses Net
| 380.423 | 52 | 73 | 236 | -105 | 154 | -1,255.774 | 7.225 | -955.011 | 283.734 | -39.59 | 52.278 | 76.332 |
| Income Before Tax
| -28.87 | -303.662 | -573.944 | -811.937 | -1,015.183 | -627.091 | -2,281.556 | -937.078 | -1,979.439 | -456.92 | -132.869 | 7.139 | -20.918 |
| Income Before Tax Ratio
| -0.012 | -0.103 | -0.257 | -0.631 | -0.846 | -0.576 | -2.463 | -0.745 | -1.856 | -0.806 | -0.288 | 0.017 | -0.066 |
| Income Tax Expense
| 2.544 | 1.65 | 1.361 | 1.68 | 2.125 | 1.413 | -109.51 | -25.413 | -18.088 | -5.127 | 1.054 | 1.269 | 1.287 |
| Net Income
| -31.415 | -305.313 | -575.094 | -812.572 | -1,016.52 | -601.424 | -2,172.046 | -911.664 | -1,961.351 | -451.793 | -133.923 | 5.869 | -22.206 |
| Net Income Ratio
| -0.013 | -0.103 | -0.257 | -0.632 | -0.847 | -0.553 | -2.345 | -0.725 | -1.839 | -0.797 | -0.291 | 0.014 | -0.07 |
| EPS
| -0.37 | -3.62 | -7.57 | -11.38 | -14.27 | -8.79 | -34.28 | -15.68 | -36.16 | -9.01 | -3.08 | 0.15 | -0.58 |
| EPS Diluted
| -0.37 | -3.62 | -7.57 | -11.38 | -14.27 | -8.79 | -34.28 | -15.68 | -36.16 | -9.01 | -3.08 | 0.15 | -0.58 |
| EBITDA
| -372.18 | -116.018 | -438.393 | -766.025 | -838.384 | -570.512 | -678.81 | -684.93 | -823.667 | -307.971 | -122.217 | 17.844 | -83.394 |
| EBITDA Ratio
| -0.153 | -0.039 | -0.196 | -0.596 | -0.699 | -0.524 | -0.733 | -0.545 | -0.772 | -0.543 | -0.265 | 0.042 | -0.263 |